Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19
NCT ID: NCT05385029
Last Updated: 2022-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
95 participants
OBSERVATIONAL
2020-05-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women
NCT02966405
Screening of Subclinical Hypothyroidism in Pregnant Women
NCT05801822
Maternal Autoimmune Thyroid Disease and Fetal Thyroxin
NCT01528904
Maternal Hypothyroidism in Pregnancy
NCT00818896
Efficacy of Low Dose Levothyroxine During Pregnancy
NCT03391154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thyroid functions in neonates born to COVID 19 positive mothers
thyroid hormone or antithyroid drugs
Thyroxine
treatment for hypothyroidism or hyperthyroidism
Neonates born to mothers without COVID 19 infection
Thyroid drugs if indicated
Thyroxine
treatment for hypothyroidism or hyperthyroidism
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thyroxine
treatment for hypothyroidism or hyperthyroidism
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
OMER B ABDELBASIT
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
OMER B ABDELBASIT
Consultant Neonatologist- Chief of Neonatal Intensive Care Unit ( NICU )
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Security Forces Hospital
Riyadh, Central, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SecurityFH OABDELBASIT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.